Journal Information
 

Audience
Trends in Cell Biology keeps research scientists, students and teachers up to date with the latest developments in cell and molecular biology, developmental biology, biochemistry, genetics, immunology and neurobiology.


Guidelines to Authors
Trends Cell Biology is divided into three main sections: Update, Opinion and Review. Articles for Trends in Cell Biology are generally commissioned by the Editor, but proposals for articles are welcome. Prospective authors should submit an abstract (120 words) plus a cover letter (two pages maximum) outlining what will be discussed in the article plus up to 20 key references via our online submission site. Full details can be found at http://www.editorialmanager.com/tcb/  Full length manuscripts cannot be submitted via this site without prior consultation with the Editor. Authors should note that all articles in Trends in Cell Biology are peer-reviewed, and commissioning does not guarantee publication.

Review and Opinion articles form the foundation of each monthly issue. Reviews are invited from leading researchers in a specific field and objectively chronicle recent and important developments in newly emerging or rapidly progressing fields. Opinion articles present a personal, authoritative viewpoint of a field or research-related subject. They can cover timely controversial topics or debates, provide a new framework for, or interpretation of, an old problem or current issue, or speculate in depth on the implications of some recently published research or data.

The Update section includes Research Focus articles and Letters to the Editor. Research Focus articles highlight topical issues and recent research papers of particular note, explaining their significance for a wide audience. The decision to publish Letters rests with the Editor, and the author(s) of any article discussed in a Letter will normally be invited to reply. Letters can address topics raised in recent issues of the journal, or other matters of general interest to cell biologists. Letters should be no more than 700 words long with a maximum of 10 references and one figure. Further details on article submission and formats can be found at http://www.editorialmanager.com/tcb/


Editorial Board
W. Baumeister, Munich, Germany
P. Cossart, Paris, France
D. Drubin, Berkeley, USA
W.C. Earnshaw, Edinburgh, UK
S. D. Emr, Ithaca, USA
A. Ephrussi, Heidelberg, Germany
S. Gasser, Geneva, Switzerland
D. Goldfarb, New York, USA
J. Gray, Cambridge, UK
A. Helenius, Zurich, Switzerland
N. Hirokawa, Tokyo, Japan
A. Horwitz, Charlottesville, USA
T. Hunter, La Jolla, USA
J. Hyams, Palmerston North, New Zealand
C. Marshall, London, UK
A. Matus, Basel, Switzerland
J. Nelson, Stanford, USA
R. Pagano, Rochester, USA
H. Pelham, Cambridge, UK
H. Ploegh, Cambridge, USA
J.R. Woodgett, Toronto, Canada


Abstracting/Indexing
Chemical Abstracts
Current Contents (Life Science)
Medline/MEDLARS Online
Nucleic Acids Abstracts
Reference Update
Science Ciation Index
SciSearch/Science Citation Index Expanded


Bibliographic Information
Commenced publication 1991
Volume 18
2008, 12 issues
ISSN: 01962-8924


Statement on publishing ethics
The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct.

Conflict of Interest Policy
The Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author’s work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict. For more information, please refer to: http://www.elsevier.com/wps/find/authorshome.authors/conflictsofinterest

Copyright statement
© 2008 Elsevier Ltd. All rights reserved.
This journal and the individual contributions contained in it are protected under copyright by Elsevier Science, and the following terms and conditions apply to their use:


Photocopying
Single photocopies of single articles may be made for personal use as allowed by national copyright laws. Permission of the publisher and payment of a fee is required for all other photocopying, including multiple or systematic copying, copying for advertising or promotional purposes, resale, and all forms of document delivery. Special rates are available for educational institutions that wish to make photocopies for non-profit educational classroom use.
Elsevier Science Rights & Permissions Department
PO Box 800
Oxford
UK OX5 1DX
Tel:+44 (0) 1865 843830
Fax: +44 (0) 1865 853333
E-mail: permissions@elsevier.co.uk

You may also contact Global Rights directly through Elsevier's home page (http://www.elsevier.com), selecting first 'Customer Support', then 'Permissions', then 'Permissions Request Form'.

In the USA, users may clear permissions and make payments through the

Copyright Clearance Center Inc
222 Rosewood Drive
Danvers
MA 01923, USA
Tel: +1 (978) 750 8400
Fax: +1 (978) 750 4744

and in the UK through the

Copyright Licensing Agency Rapid Clearance Service (CLARCS)
90 Tottenham Court Road
London, UK W1P 0LP
Tel: +44 (0) 20 7631 5555
Fax: +44 (0) 20 7436 5500

Other countries may have a local reprographic rights agency for payments.

Derivative Works
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution.
Permission of the publisher is required for all other derivative works, including compilations and translations.


Electronic Storage or Usage
Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Science Rights & Permissions Department, at the mail, fax and e-mail addresses noted above.


Notice
No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.
Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.